A letter to the editor in response to: indirect comparison of the relative vaccine effectiveness of mRNA-1283 vs. BNT162b2 vaccines against symptomatic COVID-19 among US adults
Curr Med Res Opin. 2025 May;41(5):917-919.
doi: 10.1080/03007995.2025.2502123.
Epub 2025 May 9.